Author

Joseph V Pergolizzi

NEMA Research Inc. - Cited by 10,901

Biography

Dr. Pergolizzi earned a BS in physical chemistry from St. John’s University and an MD with highest honors from Ross University School of Medicine. He completed his residency in anesthesia at Georgetown University School of Medicine and a clinical research fellowship in the Department of Medicine at Johns Hopkins University School of Medicine. He has served as NEMA CEO since 1997 with global business corporate lead direct responsibilities for turn-key clinical trial management and implementation (Phase I-IV). Prior to joining NEMA.
Title
Cited by
Year
Potential neurological manifestations of COVID-19: a narrative review
JV Pergolizzi Jr, RB Raffa, G Varrassi, P Magnusson, JA LeQuang, ...Postgraduate medicine 134 (4), 395-405, 2022202
28
2022
Opioid therapy in cancer patients and survivors at risk of addiction, misuse or complex dependency
JV Pergolizzi Jr, P Magnusson, PJ Christo, JA LeQuang, F Breve, ...Frontiers in Pain Research 2, 691720, 2021202
14
2021
Wooden chest syndrome: the atypical pharmacology of fentanyl overdose
JV Pergolizzi Jr, LR Webster, E Vortsman, J Ann LeQuang, RB RaffaJournal of Clinical Pharmacy and Therapeutics 46 (6), 1505-1508, 2021202
10
2021
Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit
JV Pergolizzi Jr, A Dahan, J Ann LeQuang, RB RaffaJournal of Clinical Pharmacy and Therapeutics 46 (6), 1501-1504, 2021202
8
2021
Treating apnea of prematurity
J Pergolizzi, A Kraus, P Magnusson, F Breve, K Mitchell, R Raffa, ...Cureus 14 (1), 2022202
7
2022
Pharmacologic agents directed at the treatment of pain associated with maladaptive neuronal plasticity
JV Pergolizzi Jr, G Varrassi, P Magnusson, F Breve, RB Raffa, PJ Christo, ...Expert opinion on pharmacotherapy 23 (1), 105-116, 2022202
7
2022
Cocaethylene: when cocaine and alcohol are taken together
J Pergolizzi, F Breve, P Magnusson, JAK LeQuang, G Varrassi, ...Cureus 1 (2), 2022202
4
2022
Exploring the implications of new-onset diabetes in COVID-19: a narrative review
J Pergolizzi, JAK LeQuang, F Breve, PM Magnusson, G Varrassi, ...Cureus 15 (1), 20220
3
2023
Pharmacotherapeutic management of trigeminal neuropathic pain: an update
JV Pergolizzi Jr, C Gharibo, P Magnusson, F Breve, JA LeQuang, ...Expert Opinion on Pharmacotherapy 2 (10), 1155-1164, 2022202
3
2022
Multimechanistic single-entity combinations for chronic pain control: a narrative review
J Pergolizzi, P Magnusson, F Coluzzi, F Breve, JAK LeQuang, G Varrassi, ...Cureus 14 (6), 2022202
3
2022
Influences of gender on intravenous nalbuphine actions after major abdominal surgery: a multicenter study
AE Ayad, OH Salman, AMF Ibrahim, WAM Al-Taher, AM Mishriky, ...Pain and Therapy 10 (2), 1215-12, 2021202
3
2021
Reimagining how we treat acute pain: a narrative review
P Castroman, O Quiroga, VM Rojals, M Gómez, E Moka, J Pergolizzi Jr, ...Cureus 14 (4), 2022202
3
2022
Pain Management and COVID-19: A Latin American Perspective
M Guerrero, P Castroman, O Quiroga, MB Cook, MAN Tamayo, ...Cureus 14 (), 2022202
3
2022
Considerations for better management of postoperative pain in light of chronic postoperative pain: a narrative review
M Gómez, CE Izquierdo, VM Rojals, J Pergolizzi Jr, RP Sanchez, ...Cureus 14 (4), 0
2
2022
The conundrum of polysubstance overdose
JV Pergolizzi Jr, A Dahan, JA LeQuang, RB RaffaJournal of Clinical Pharmacy and Therapeutics 46 (5), 1189-1193, 010
2
2021
Effects of digoxin in heart failure (HF) with reduced ejection fraction (EF)
RR Parikh, KR Patel, JV Pergolizzi Jr, F Breve, P Magnusson, K Patel, ...Cureus 14 (3), 0
2
2022
The epidemiology of apnoea of prematurity
JV Pergolizzi Jr, P Fort, TL Miller, JA LeQuang, RB RaffaJournal of clinical pharmacy and therapeutics 47 (5), 685-693, 0
2
2022
Opioids in the Elderly Patients with Cognitive Impairment: A Narrative Review
M Rekatsina, A Paladini, O Viswanath, I Urits, D Myrcik, J Pergolizzi, ...Pain and Therapy 11 (), 381-394, 0
2
2022
Current and emerging COX inhibitors for treating postoperative pain following oral surgery
JV Pergolizzi, F Breve, P Magnusson, JAK LeQuang, G VarassiExpert Opinion on Pharmacotherapy 4 (3), 347-358, 030
2
2023